Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy

scientific article published on 15 April 2017

Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JHIN.2017.04.007
P698PubMed publication ID28545829

P2093author name stringY Cai
Y Kang
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectfecesQ496
liver diseaseQ929737
chronic liver diseaseQ5113984
P304page(s)342-348
P577publication date2017-04-15
P1433published inJournal of Hospital InfectionQ15746468
P1476titleGut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy
P478volume96

Reverse relations

cites work (P2860)
Q47573299Current advances in the elimination of hepatitis B in China by 2030.
Q64954491Decreased levels of serum zonulin and copeptin in chronic Hepatitis-B patients.
Q89612797Exposure to copper altered the intestinal microbiota in Chinese brown frog (Rana chensinensis)
Q61814448Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
Q92857451Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Q91795154Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease
Q55115142Numerical analyses of intestinal microbiota by data mining.
Q54202324On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B.
Q59353836The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection
Q91584430The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption